Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Schizophr Res. 2013 Mar 1;146(0):184–189. doi: 10.1016/j.schres.2013.02.001

Table 1.

Demographic, clinical characteristics, and dietary total antioxidant capacity (TAC) intake.

Normal Controls (N = 25) Schizophrenia Patients (N = 29) Statistics P values
Age (years) 38.76±13.721 41.10±13.81 0.009 0.55
Sex (male:female) 11:14 20:9 2.48 0.12
Smoker:Nonsmoker 7:18 8:21 0.00 1.00
Education (year) 13.4±1.6 12.1±2.0 5.77 0.020
Age of illness onset (year) n/a 21.4±8.4 n/a n/a
Duration of illness (year) n/a 20.0±13.4 n/a n/a
BPRS score n/a 43.28±9.93 n/a n/a
UPSA-2 102.9±10.3 90.7±10.5 17.62 <0.001
Fasting duration (hours) 12.18±2.81 12.48±3.64 0.11 0.74
GSH (μmol/L) 800.50±201.73 516.50±238.40 21.06 <0.001
GSSG (μmol/L) 19.96±24.82 27.94±23.19 8.56 0.005
%GSSG 2.40±3.02 12.43±24.18 2.28 0.023
TAC intake/week (μmol FRAP/week) 12620.6 + 1046.2 15257.7 + 1800.0 1.48 0.23
1

Values are mean ± sd. BPRS: Brief Psychiatric Rating Scale total score. UPSA-2: the University of California San Diego Performance-based Skills Assessment, 2nd edition total score (the data for controls was from 23 subjects because 2 controls did not complete UPSA-2).